Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Immucell (ICCC) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Immucell (ICCC) over the last 15 years, with Q3 2025 value amounting to $708667.0.

  • Immucell's Accumulated Depreciation & Amortization rose 331.52% to $708667.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $708667.0, marking a year-over-year increase of 331.52%. This contributed to the annual value of $2.7 million for FY2024, which is 35.67% down from last year.
  • According to the latest figures from Q3 2025, Immucell's Accumulated Depreciation & Amortization is $708667.0, which was up 331.52% from $22.3 million recorded in Q2 2025.
  • Immucell's 5-year Accumulated Depreciation & Amortization high stood at $22.3 million for Q2 2025, and its period low was $685927.0 during Q3 2024.
  • For the 5-year period, Immucell's Accumulated Depreciation & Amortization averaged around $13.4 million, with its median value being $15.2 million (2022).
  • Per our database at Business Quant, Immucell's Accumulated Depreciation & Amortization soared by 2003.21% in 2021 and then plummeted by 9614.95% in 2024.
  • Immucell's Accumulated Depreciation & Amortization (Quarter) stood at $14.0 million in 2021, then rose by 13.45% to $15.9 million in 2022, then plummeted by 82.74% to $2.7 million in 2023, then decreased by 0.36% to $2.7 million in 2024, then crashed by 74.04% to $708667.0 in 2025.
  • Its Accumulated Depreciation & Amortization stands at $708667.0 for Q3 2025, versus $22.3 million for Q2 2025 and $21.7 million for Q1 2025.